Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
scam company do not merge with a nasdaq company and the deal worth $95m learn how to read SEC filing. Most of the drugs are already approved in Europe. 5B to 6B company in five to six years
Here since late 2020 Dr came and I was excited after looking at his resume. He scared the hell out of the retailer. I firmly believe there is something more to the story.
Here comes the idiots!!
LEAS closed out the week remaining on Scam Alert!!
This 8-K came out this week and reading it , sure appears that something is in the works.
--
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=317765470&type=HTML&symbol=RWOD&cdn=b608cb75fcb7ae08e423097d3daf2af4&companyName=Redwoods+Acquisition+Corp.&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2023-09-25
5 minutes left folks.
Let’s do it in the last 5 min before market close!
News after market close?
Hang tight folks. Level 2 they are trying to bring down the bid , but no one is really going for it . We are going to stay in this range and look for update into next week on RWOD status . This is READY to start moving on any more volume with a Catalyst(s) and will move quickly , we are seeing it now.
Yeah man… hopefully we get some good updates soon
I have been telling one basher for weeks now that wishing for a thing doesn't make it so.....he wasn't listening.
.0029s up
Not .0009s like what has been bashed into our ears for weeks. We all know merger news is getting close.
FOMO is about right. We all know.
who ever lacks patience and sell this new company stock is a damn fool and i wont feel sorry for them selling too soon.
new company is valued at 94 million dollars with 54 million in cash.
the company they are merging with have millions in cash on hand so they can afford to do a stock buy back.
I don’t think they will, they will probably update us next PR and if so, that will skyrocket this.
i dont think there will be a RS but there might be a stock buy back who knows time will tell.
Would be nice to get a juicy update on the merger/No RS news to further ignite this to new levels!!
I am very patient here so it doesn't matter to me, ill see where this is at the end of the year ,mergers take time to be fully completed.
New highs today or close at HOD?
Yep, time for a high and major RUN NORTH!!!
Hopefully if not today next week....lets see it after hours next week............let the FOMO get rolling....................LEAS
Hope everyone held there shares and people didnt get talked out of it....................LEAS
#9 on the break out board. moving on up to the east side.
Let’s bring back fomo here
i am very glad i never sold a single share.
like i said yesterday next month we will see where we are as this merger come together and the full plan is rolled out patience is key here.
.0027 up
All whiners have exited by now below .002
Let’s see if the chase begins!
RUN coming, break that high of .0059!!! $LEAS
Nice start for a Friday… something brewing?? Glad I loaded up last week.
Next month should tell where we will be the patient ones will be rewarded.
Tomorrow or next week?
We need a new high above .0059!!!
tik tok tik tok its just a matter of time now.
Noted , however we need more trades and more volume to get the Liquidity going here.
23's thinning, see if we can see .0024 by EOD!!! $LEAS
very sloooooow stair step. ill take that any time, patience is key here. the days of otc stock shooting up 100% or higher in a few hours is over for now.
Should have waited till the last 30seconds of trading, but got an itchy trigger finger.
I know better than that.
Retail on the Ask now.,
When/if there’s a reason this will move quickly there’s hardly anything on the ask…we’ll see
Please!!! LOL!
Try saying "Please"
Medical product development and commercialization. The Company recently acquired five generic oncology drugs approved and manufactured in Germany and they plan to gain approval for these drugs in the US in 2023. The Company is preparing for a pivotal Phase 3 study of an anti-cancer antibody product that is highly similar to Genentech/Roche's brand name Avastin (bevacizumab), the Company has licensed a needle-free jet injector for drug delivery, and the Company is in the pre-clinical stages of development of a gene therapy product candidate based on the delivery of a human alpha-Klotho gene and protein to prevent and/or treat neurodegenerative diseases such as Alzheimer's and Lou Gehrig's disease (ALS). Other product candidates will stem from these platform technologies of pharmaceuticals, biologics, and gene therapy.
The Company's medical R&D facilities are in the U.S. (near the University of Nebraska Medical Center, Omaha, Nebraska) and in Barcelona, Spain (Autonomous Universitat de Barcelona). Each R&D facility is comprised of over 4,000 sq ft of R&D and office space, currently leased and equipped with research equipment, incubators, tissue culture facilities for production of plasmid DNA, HEPA-filtered hoods for aseptic handling, and testing equipment (PCR, spectrophotometers, microscopes, etc). The generic oncology drugs are manufactured in Germany. With future funding, the Company plans to acquire or build a GMP manufacturing facility to supply novel plasmid DNA ("transgenes") to be used in gene therapy programs, to provide contract manufacturing revenue, and for commercial product manufacturing.